MedTrace Logo

Neurocognitive Functions of Recovered COVID-19 Patients

NCT04622748 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2020-11-10

No results posted yet for this study

Summary

This study is carried on in Wuchang Hospital in Wuhan, China. The investigators plan to recruit 80 patients with COVID-19 and 80 matched healthy control. Using the design of case-control study, the study aims to assess the neurocognitive functions such as executive function and attentional bias in recovered patients with COVID-19 under normal and stress conditions, and to analyze the influencing factors of neurocognitive functions, such as mental health conditions, inflammation indicators and cardiopulmonary function.

Conditions

Interventions

BEHAVIORAL

Trier Social Stress Test

8-min oral calculation and 5-min speech

Sponsors & Collaborators

  • Peking University Sixth Hospital

    collaborator OTHER

  • Wuhan Wuchang Hospital

    collaborator UNKNOWN

  • National Institute on Drug Dependence, China

    lead OTHER

Principal Investigators

  • Lin Lu, Dr. · National Institute on Drug Dependence, Peking University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-10
Primary Completion
2020-12-10
Completion
2020-12-10

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04622748 on ClinicalTrials.gov